Latest Breaking News On - Epygenix therapeutics inc - Page 1 : comparemela.com

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its ...

WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year

Dravet Syndrome Global Market Report 2023: Enhanced Genetic Testing Capabilities Fuels Sector Growth

/PRNewswire/ The "Dravet Syndrome Market Share, Size, Trends, Industry Analysis Report, By Type of Seizures; By Diagnosis; By Severity; By Treatment; By.

Dravet syndrome treatment market size to increase by USD 575.14 million; North America to contribute 38% of market growth

/PRNewswire/ The Dravet Syndrome Treatment Market by Product, Distribution Channel, and Geography - Forecast and Analysis 2023-2027 report has been.

Dravet syndrome treatment market size to increase by USD 575.14 million; North America to contribute 38% of market growth

/PRNewswire/ The Dravet Syndrome Treatment Market by Product, Distribution Channel, and Geography - Forecast and Analysis 2023-2027 report has been.